FDA Increases Enforcement Against Manufacture of Unapproved Drugs
This article was originally published in The Gold Sheet
Executive Summary
Makers of unapproved drugs will be targeted for enforcement.
You may also be interested in...
FDA Noticed Labeling Problems With Roxane Drugs Six Months Before Morphine Alert
Roxane's high-potency morphine packaging is being redesigned with bold colors to distinguish it from other products after overdoses including deaths.
Latest FDA Warning Letters Highlight Aseptic Processing Issues
A number of recent FDA warning letters focused on GMP issues with aseptic processing, signaling the agency’s continuing concern about contamination prevention.
Latest FDA Warning Letters Highlight Aseptic Processing Issues
A number of recent FDA warning letters focused on GMP issues with aseptic processing, signaling the agency’s continuing concern about contamination prevention.